Australia's most cutting-edge cancer researchers have joined forces with a Wagga charity in a bid to stamp out melanoma deaths altogether.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
On Thursday, the Amie St Clair Melanoma Trust merged with the Melanoma Institute Australia, and together they launched their four-pronged approach to achieve zero melanoma deaths.
The biggest, pointiest prong will be the introduction of clinical trials in Wagga, where they will be testing the newest, most advanced treatment in Australia.
Professor Georgina Long said research into melanoma had brought the field forward in leaps and bounds, and she was optimistic that a zero-death target was within reach.
"When I started in the field less than 5 per cent of people would survive to five years, and now it's over 50 per cent," Professor Long said.
"Fifty per cent is great, but we've still got a lot of work to do."
In other news:
Her optimism is shared by Professor Richard Scolyer, who said the partnership would solve the tyranny of distance suffered in regional Australia.
"It's a great opportunity for the Wagga medical community and we're very excited about the new opportunities for patients it will bring," Professor Scolyer said.
"By participating in these trials the Wagga community are going to have the opportunity to influence clinical practice around the world."
Annette St Clair said she couldn't have done it without the support of the Wagga community, who always came together in a pinch.
"Our wonderful volunteers have worked so hard to build the Amie St Clair Melanoma Trust over the last 10 years," she said.